What is LOPJLB’s current signal on SPRO?

LOPJLB’s latest quantitative signal on Spero Therapeutics, Inc. (SPRO) is SELL in a RECOVERY regime. Signals are updated daily.

What market regime is SPRO in?

Spero Therapeutics, Inc. (SPRO) is currently classified in the RECOVERY HMM market regime on LOPJLB.

What does Spero Therapeutics, Inc. (SPRO) do?

Spero Therapeutics, Inc. is a biopharmaceutical firm in the clinical development stage, primarily focused on discovering, advancing, and commercializing innovative treatments for multi-drug resistant (MDR) bacterial infections and rare diseases within the United States. The company's pipeline includes several key therapeutic candidates: tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-c…

Where is Spero Therapeutics, Inc. based / listed?

Spero Therapeutics, Inc. is based in US, listed on NASDAQ.

Spero Therapeutics, Inc. (SPRO)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$1.20+5.26%Close

SELLRECOVERY · day 1

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-30

Market cap: $69M
Beta: 1.48
P/E (TTM): 8.50

Short % float: 1.71%
Days to cover: 1.0
SI change: -18.6%

1W: +0.84%
1M: +7.14%

vs SPY 1W: -0.32%
vs SPY 1M: +4.15%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Key stats

Prediction markets

Company news